Brighter has now obtained all outstanding medical device regulatory approvals in the United Arab Emirates
All of the outstanding medical device regulatory approvals for Actiste® Diabetes Management as a Service (the “Actiste Service”) have now been obtained in the UAE, which means that Brighter has now received all the regulatory approvals required to commercialize the Actiste Service in the country. On Monday November 9 Brighter announced that the Company's pioneering diabetes management solution, Actiste®, has received market approval